We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

179 hedge funds and large institutions have $611M invested in ADMA Biologics in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more call options, than puts

Call options by funds: $2.39M | Put options by funds: $994K

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

12% more capital invested

Capital invested by funds: $547M → $611M (+$63.5M)

10% more funds holding

Funds holding: 163 → 179 (+16)

0.03% more ownership

Funds ownership: 74.42% → 74.46% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

6% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 62

Holders
179
Holders Change
+16
Holders Change %
+9.82%
% of All Funds
2.81%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
29
Increased
58
Reduced
62
Closed
13
Calls
$2.39M
Puts
$994K
Net Calls
+$1.4M
Net Calls Change
+$319K

Top Buyers

1
DCM
Driehaus Capital Management
Illinois
+$12.7M
2
American Century Companies
American Century Companies
Missouri
+$10.9M
3
TCM
Tang Capital Management
California
+$4.67M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.53M
5
SCM
Stonepine Capital Management
Oregon
+$4.19M

Top Sellers

1
State Street
State Street
Massachusetts
-$9.17M
2
Millennium Management
Millennium Management
New York
-$9.13M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.4M
4
BCM
Bridgeway Capital Management
Texas
-$5.86M
5
VCIM
Velan Capital Investment Management
Georgia
-$4.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
IPW
176
Impact Partnership Wealth
Georgia
$1.56K +$1.57K +424 New
Carson Wealth (CWM LLC)
177
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
NC
178
NewSquare Capital
Pennsylvania
$738 – – –
GI
179
Gradient Investments
Minnesota
$4 +$4 +1 New
Point72 Asset Management
180
Point72 Asset Management
Connecticut
– -$6.4M -1,934,576 Closed
Marshall Wace
181
Marshall Wace
United Kingdom
– -$380K -114,900 Closed
Group One Trading
182
Group One Trading
Illinois
– -$297K -80,127 Closed
DMKJ
183
David M. Knott Jr
– -$259K -78,143 Closed
SG Americas Securities
184
SG Americas Securities
New York
– -$194K -58,507 Closed
MS
185
Maven Securities
Jersey
– -$166K -50,000 Closed
BPA
186
Beacon Pointe Advisors
California
– -$49.4K -14,915 Closed
BCM
187
Bayesian Capital Management
New York
– -$36.9K -11,146 Closed
IAA
188
Independent Advisor Alliance
North Carolina
– -$33.7K -10,193 Closed
BAM
189
Belpointe Asset Management
Nevada
– -$6.98K -2,110 Closed
ASN
190
Advisory Services Network
Georgia
– -$1.66K -500 Closed
TCWA
191
Ten Capital Wealth Advisors
Washington
– -$662 -200 Closed
4 5 6 7
8

ADMA Hedge Fund Activity: Q2 2023 in Review

179 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q2 2023, worth a combined $611M — up 12% from $547M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ADMA positions and 13 closed out — a net gain of 16 holders — while 58 added to existing stakes and 62 trimmed.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $12.7M. The largest seller was State Street, cutting an estimated $9.17M.

  • 179 institutional investors held ADMA Biologics (ADMA) as of Q2 2023, up from 163 in Q1 2023.
  • Funds reported $611M of ADMA Biologics stock for Q2 2023, up 12% quarter-over-quarter.
  • 29 funds opened new ADMA Biologics positions in Q2 2023 and 13 closed out, a net change of +16 holders.
  • The largest ADMA Biologics buyer in Q2 2023 was Driehaus Capital Management, an estimated $12.7M added.
  • The largest ADMA Biologics seller in Q2 2023 was State Street, an estimated $9.17M sold.

Based on aggregated 13F filings for Q2 2023.